0001610717-24-000205.txt : 20240412 0001610717-24-000205.hdr.sgml : 20240412 20240412162340 ACCESSION NUMBER: 0001610717-24-000205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240410 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sushil CENTRAL INDEX KEY: 0001860609 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 24841795 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 500 UNICORN PARK, THIRD FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 form4.xml X0508 4 2024-04-10 0001628171 Revolution Medicines, Inc. RVMD 0001860609 Patel Sushil C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DR REDWOOD CITY CA 94063 true true Common Stock 2024-04-10 4 M 0 2155 16.8 A 17855 D Common Stock 2024-04-10 4 S 0 2155 37 D 15700 D Stock Option (Right to Buy) 16.8 2024-04-10 4 M 0 2155 0 D 2032-06-15 Common Stock 2155 34645 D Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023. Includes 10,450 restricted stock units. The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Jack Anders, as Attorney-in-fact for Sushil Patel 2024-04-12